We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KDNY
9451
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$307K ﹤0.01%
+15,600
New +$313K
UBA
9452
CALL
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$307K ﹤0.01%
19,800
+6,300
+47% +$107K
SAFE
9453
CALL
DELISTED
Safehold Inc.
SAFE
$307K ﹤0.01%
11,600
-8,900
-43% -$347K
ARDX icon
9454
CALL
Ardelyx
ARDX
$1.05B
$306K ﹤0.01%
257,100
+113,500
+79% +$108K
GOTU icon
9455
Gaotu Techedu
GOTU
$401M
$306K ﹤0.01%
252,573
+196,327
+349% +$317K
LXRX icon
9456
Lexicon Pharmaceuticals
LXRX
$1.03B
$306K ﹤0.01%
127,193
-38,486
-23% -$107K
MDEV icon
9457
First Trust Indxx Medical Devices ETF
MDEV
$3.22M
$306K ﹤0.01%
18,779
-11
-0.1% -$204
TTT icon
9458
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.6M
$306K ﹤0.01%
4,019
-13,554
-77% -$810K
SILK
9459
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$306K ﹤0.01%
+6,800
New +$292K
HAAC
9460
PUT
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$306K ﹤0.01%
30,700
-39,200
-56% -$390K
AUDC icon
9461
CALL
AudioCodes
AUDC
$250M
$305K ﹤0.01%
+14,000
New +$315K
BWMX icon
9462
Betterware México
BWMX
$613M
$305K ﹤0.01%
41,104
-10,732
-21% -$99.4K
CHAU icon
9463
CALL
Direxion Daily CSI 300 China A Share Bull 2X ETF
CHAU
$95.3M
$305K ﹤0.01%
16,100
-1,400
-8% -$33.9K
CLOU icon
9464
CALL
Global X Cloud Computing ETF
CLOU
$274M
$305K ﹤0.01%
19,100
+1,700
+10% +$29.5K
CNCR
9465
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$305K ﹤0.01%
+20,821
New +$336K
FN icon
9466
PUT
Fabrinet
FN
$20.4B
$305K ﹤0.01%
3,200
+600
+23% +$57.8K
HHH icon
9467
CALL
Howard Hughes
HHH
$3.98B
$305K ﹤0.01%
5,770
+1,574
+38% +$101K
USCI icon
9468
US Commodity Index
USCI
$375M
$305K ﹤0.01%
5,946
+1,706
+40% +$91.7K
YDEC icon
9469
FT Vest International Equity Moderate Buffer ETF December
YDEC
$167M
$305K ﹤0.01%
17,837
-96
-0.5% -$1.79K
TWNK
9470
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$305K ﹤0.01%
+13,115
New +$298K
POTX
9471
DELISTED
Global X Cannabis ETF
POTX
$305K ﹤0.01%
+22,240
New +$374K
ATLC icon
9472
Atlanticus Holdings
ATLC
$1.56B
$304K ﹤0.01%
11,582
+2,196
+23% +$75.4K
BLKB icon
9473
PUT
Blackbaud
BLKB
$2.05B
$304K ﹤0.01%
6,900
-51,600
-88% -$2.78M
DFTX
9474
Definium Therapeutics
DFTX
$5.73B
$304K ﹤0.01%
86,937
-29,185
-25% -$280K
MOFG
9475
DELISTED
MidWestOne Financial Group
MOFG
$304K ﹤0.01%
11,127
+41
+0.4% +$1.25K

Similar funds

Citadel Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Citadel Advisors deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
  • Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Citadel Advisors opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.